"The central bank's recent proactive stance with its interventions ... seems to be here to stay in the near term," they wrote in a note, citing increased nervousness over inflation. "This adds another layer of support for the real."
The federally-funded Fiocruz biomedical center in Rio de Janeiro is still awaiting its first shipment of ingredients for AstraZeneca's vaccine, pending Chinese export approval.
"The situation is serious," said Perfeito, who noted that "the central problem is not the lack of money, but the lack of a clear plan" in a country that still does not have a start date for vaccinations against Covid-19.
A Supreme Court ruling would clear the way for São Paulo state to start vaccinating people in January, as planned, with doses of China's CoronaVac vaccine made by Sinovac Biotech Ltd.